ECOG E3200 Dette var et fase III, randomiseret, aktivt- kontrolleret, ublindet studie, som undersøgte Avastin 10 mg/ kg i kombination med leucovorin og 5- fluorouracil bolus efterfulgt af 5 - fluorouracil infusion med iv oxaliplatin (FOLFOX- 4), administreret hver 2. uge til tidligere behandlede (2. linje) patienter med fremskreden kolorektal kræft.
ECOG E3200 This was a phase III randomised, active-controlled, open-label study investigating Avastin 10 mg/ kg in combination with leucovorin with 5-fluorouracil bolus and then 5-fluorouracil infusional, with IV oxaliplatin (FOLFOX-4), administered on a 2-weekly schedule in previously-treated patients (second line) with advanced colorectal cancer.